196 related articles for article (PubMed ID: 20698584)
1. Human serum processing and analysis methods for rapid and reproducible N-glycan mass profiling.
Kronewitter SR; de Leoz ML; Peacock KS; McBride KR; An HJ; Miyamoto S; Leiserowitz GS; Lebrilla CB
J Proteome Res; 2010 Oct; 9(10):4952-9. PubMed ID: 20698584
[TBL] [Abstract][Full Text] [Related]
2. A glycomics approach to the discovery of potential cancer biomarkers.
An HJ; Lebrilla CB
Methods Mol Biol; 2010; 600():199-213. PubMed ID: 19882130
[TBL] [Abstract][Full Text] [Related]
3. High-throughput quantitative analysis of total N-glycans by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Jeong HJ; Kim YG; Yang YH; Kim BG
Anal Chem; 2012 Apr; 84(7):3453-60. PubMed ID: 22455307
[TBL] [Abstract][Full Text] [Related]
4. A Novel Mass Spectrometry Platform for Multiplexed N-Glycoprotein Biomarker Discovery from Patient Biofluids by Antibody Panel Based N-Glycan Imaging.
Black AP; Liang H; West CA; Wang M; Herrera HP; Haab BB; Angel PM; Drake RR; Mehta AS
Anal Chem; 2019 Jul; 91(13):8429-8435. PubMed ID: 31177770
[TBL] [Abstract][Full Text] [Related]
5. Automated Plasma Glycomics with Linkage-Specific Sialic Acid Esterification and Ultrahigh Resolution MS.
Vreeker GCM; Nicolardi S; Bladergroen MR; van der Plas CJ; Mesker WE; Tollenaar RAEM; van der Burgt YEM; Wuhrer M
Anal Chem; 2018 Oct; 90(20):11955-11961. PubMed ID: 30230816
[TBL] [Abstract][Full Text] [Related]
6. Sensitive and robust MALDI-TOF-MS glycomics analysis enabled by Girard's reagent T on-target derivatization (GTOD) of reducing glycans.
Zhang Y; Wang B; Jin W; Wen Y; Nan L; Yang M; Liu R; Zhu Y; Wang C; Huang L; Song X; Wang Z
Anal Chim Acta; 2019 Feb; 1048():105-114. PubMed ID: 30598139
[TBL] [Abstract][Full Text] [Related]
7. Glycomic approach for potential biomarkers on prostate cancer: profiling of N-linked glycans in human sera and pRNS cell lines.
de Leoz ML; An HJ; Kronewitter S; Kim J; Beecroft S; Vinall R; Miyamoto S; de Vere White R; Lam KS; Lebrilla C
Dis Markers; 2008; 25(4-5):243-58. PubMed ID: 19126968
[TBL] [Abstract][Full Text] [Related]
8. A Quantitative Glycomics and Proteomics Combined Purification Strategy.
Hecht ES; McCord JP; Muddiman DC
J Vis Exp; 2016 Mar; (109):. PubMed ID: 27023253
[TBL] [Abstract][Full Text] [Related]
9. Optimized workflow for preparation of APTS-labeled N-glycans allowing high-throughput analysis of human plasma glycomes using 48-channel multiplexed CGE-LIF.
Ruhaak LR; Hennig R; Huhn C; Borowiak M; Dolhain RJ; Deelder AM; Rapp E; Wuhrer M
J Proteome Res; 2010 Dec; 9(12):6655-64. PubMed ID: 20886907
[TBL] [Abstract][Full Text] [Related]
10. Permethylated N-glycan analysis with mass spectrometry.
Lin Z; Lubman DM
Methods Mol Biol; 2013; 1007():289-300. PubMed ID: 23666731
[TBL] [Abstract][Full Text] [Related]
11. Glycomic profiling of tissue sections by LC-MS.
Hu Y; Zhou S; Khalil SI; Renteria CL; Mechref Y
Anal Chem; 2013 Apr; 85(8):4074-9. PubMed ID: 23438902
[TBL] [Abstract][Full Text] [Related]
12. Comparative glycomic profiling in esophageal adenocarcinoma.
Hammoud ZT; Mechref Y; Hussein A; Bekesova S; Zhang M; Kesler KA; Novotny MV
J Thorac Cardiovasc Surg; 2010 May; 139(5):1216-23. PubMed ID: 20412957
[TBL] [Abstract][Full Text] [Related]
13. Quantitative O-glycomics based on improvement of the one-pot method for nonreductive O-glycan release and simultaneous stable isotope labeling with 1-(d
Wang C; Zhang P; Jin W; Li L; Qiang S; Zhang Y; Huang L; Wang Z
J Proteomics; 2017 Jan; 150():18-30. PubMed ID: 27585995
[TBL] [Abstract][Full Text] [Related]
14. N-glycan MALDI Imaging Mass Spectrometry on Formalin-Fixed Paraffin-Embedded Tissue Enables the Delineation of Ovarian Cancer Tissues.
Everest-Dass AV; Briggs MT; Kaur G; Oehler MK; Hoffmann P; Packer NH
Mol Cell Proteomics; 2016 Sep; 15(9):3003-16. PubMed ID: 27412689
[TBL] [Abstract][Full Text] [Related]
15. Simplifying Glycan Profiling through a High-Throughput Micropermethylation Strategy.
Shajahan A; Supekar NT; Chapla D; Heiss C; Moremen KW; Azadi P
SLAS Technol; 2020 Aug; 25(4):367-379. PubMed ID: 32364434
[TBL] [Abstract][Full Text] [Related]
16. Reductive chemical release of N-glycans as 1-amino-alditols and subsequent 9-fluorenylmethyloxycarbonyl labeling for MS and LC/MS analysis.
Wang C; Qiang S; Jin W; Song X; Zhang Y; Huang L; Wang Z
J Proteomics; 2018 Sep; 187():47-58. PubMed ID: 29885470
[TBL] [Abstract][Full Text] [Related]
17. Glycan reductive isotope labeling for quantitative glycomics.
Xia B; Feasley CL; Sachdev GP; Smith DF; Cummings RD
Anal Biochem; 2009 Apr; 387(2):162-70. PubMed ID: 19454239
[TBL] [Abstract][Full Text] [Related]
18. Towards automation of glycomic profiling of complex biological materials.
Shubhakar A; Pang PC; Fernandes DL; Dell A; Spencer DIR; Haslam SM
Glycoconj J; 2018 Jun; 35(3):311-321. PubMed ID: 29909447
[TBL] [Abstract][Full Text] [Related]
19. Providing Bionic Glycome as internal standards by glycan reducing and isotope labeling for reliable and simple quantitation of N-glycome based on MALDI- MS.
Qin W; Zhang Z; Qin R; Han J; Zhao R; Gu Y; Pan Y; Gu J; Ren S
Anal Chim Acta; 2019 Nov; 1081():112-119. PubMed ID: 31446948
[TBL] [Abstract][Full Text] [Related]
20. Antibody Panel Based N-Glycan Imaging for N-Glycoprotein Biomarker Discovery.
Black AP; Angel PM; Drake RR; Mehta AS
Curr Protoc Protein Sci; 2019 Dec; 98(1):e99. PubMed ID: 31721442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
